Home> Halaven> Halaven Side Effects> Page 4

Your Halaven Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.

side effects patient, 50 years of age, was diagnosed with breast cancer recurrent and took Halaven Patient was hospitalized.. View more Serious Adverse Events reported to FDA.

View and Report Halaven Side Effects

Click Check Boxes Below to Submit a Side Effect or Use a Link for Additional Health Information
Tachycardia (1)
>>View All User Submitted Halaven Side Effects

List of Halaven Adverse Effects reported to US Food and Drug Administration (FDA)

  Showing 101-125 of 165 

Interstitial Lung Disease (7955049-9)
on Nov 22, 2011 Female patient from JAPAN , 50 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Halaven dosage: N/A. Patient was hospitalized.

Hepatic Cirrhosis (7954737-8)
Patient was taking Halaven. Patient had the following side effects: hepatic cirrhosis on Nov 23, 2011 from GERMANY Additional patient health information: Female patient , 46 years of age, was diagnosed with
  • breast cancer
and. Halaven dosage: N/A.

Fatigue, Interstitial Lung Disease, Thrombotic Thrombocytopenic Purpura (7954330-7)
Adverse event was reported on Nov 22, 2011 by a Female patient taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
and. Location: JAPAN , 50 years of age, After Halaven was administered, patient had the following side effects: fatigue, interstitial lung disease, thrombotic thrombocytopenic purpura. Patient was hospitalized.

Malaise, Neutropenia, Anaemia, Lymphopenia, Febrile Neutropenia, Leukopenia, Pneumonia (7954268-5)
on Nov 21, 2011 Female patient from JAPAN , 52 years of age, weighting 114.6 lb, was treated with Halaven. Patient experienced the following unwanted or unexpected effects: malaise, neutropenia, anaemia, lymphopenia, febrile neutropenia, leukopenia, pneumonia. Halaven dosage: N/A. Patient was hospitalized.


Neoplasm Malignant, Bacteraemia (7950046-1)
on Nov 09, 2011 Female patient from SPAIN , 48 years of age, was treated with Halaven. Patient had the following side effects: neoplasm malignant, bacteraemia. Halaven dosage: N/A.

Hepatic Failure (7941818-8)
Patient was taking Halaven. After Halaven was administered, patient had the following side effects: hepatic failure on Nov 14, 2011 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with
  • metastases to liver
and. Halaven dosage: N/A.

Leukopenia, Febrile Neutropenia, C-reactive Protein Increased (7930913-5)
Adverse event was reported on Nov 10, 2011 by a Female patient taking Halaven (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: leukopenia, febrile neutropenia, c-reactive protein increased.
Patient also using the following medications:
  • Loxonin
Patient was hospitalized.

Pain, Feeling Hot, Headache (7928220-X)
on Nov 07, 2011 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with
  • breast cancer recurrent
  • metastases to lymph nodes
  • stomatitis
  • metastases to lung
and was treated with Halaven. Patient had the following side effects: pain, feeling hot, headache. Halaven dosage: N/A. Patient was hospitalized.

Pyrexia, Sepsis (7927620-1)
on Nov 08, 2011 Female patient from CANADA , weighting 154.3 lb, was treated with Halaven. After Halaven was administered, patient had the following side effects: pyrexia, sepsis. Halaven dosage: N/A.

Cerebrovascular Accident (7912611-7)
Patient was taking Halaven. Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Nov 03, 2011 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, weighting 165.3 lb, . Halaven dosage: N/A.

Pyrexia, Rash, Toxic Epidermal Necrolysis (7910211-6)
Adverse event was reported on Nov 01, 2011 by a Female patient taking Halaven (Dosage: N/A) . Location: UNITED KINGDOM , weighting 165.3 lb, Patient had the following side effects: pyrexia, rash, toxic epidermal necrolysis.
Patient also using the following medications:
  • Phenytoin
  • Acetaminophen
Patient was hospitalized.

Neutropenia, Sensation Of Heaviness, Stomatitis, Neuropathy Peripheral, Pleural Effusion (7909270-6)
on Nov 04, 2011 Female patient from JAPAN , 67 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. After Halaven was administered, patient had the following side effects: neutropenia, sensation of heaviness, stomatitis, neuropathy peripheral, pleural effusion. Halaven dosage: N/A. Patient was hospitalized.

Fatigue, Thrombotic Thrombocytopenic Purpura, Interstitial Lung Disease (7906387-7)
on Nov 01, 2011 Female patient from JAPAN , 50 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. Patient experienced the following unwanted or unexpected effects: fatigue, thrombotic thrombocytopenic purpura, interstitial lung disease. Halaven dosage: N/A. Patient was hospitalized.

Toxic Epidermal Necrolysis, Pyrexia, Herpes Zoster Disseminated, Rash (7901790-3)
Patient was taking Halaven. Patient had the following side effects: toxic epidermal necrolysis, pyrexia, herpes zoster disseminated, rash on Nov 08, 2011 from UNITED KINGDOM Additional patient health information: Female patient , 42 years of age, weighting 165.3 lb, was diagnosed with
  • breast cancer metastatic
and. Halaven dosage: Unk.
Patient also using the following medications:
  • Paracetamol
  • Phenytoin (Unk)
Patient was hospitalized.

Respiratory Failure (7897596-4)
Adverse event was reported on Oct 28, 2011 by a Female patient taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
  • metastases to lung
  • metastases to lymph nodes
  • metastases to bone
and. Location: JAPAN , 58 years of age, weighting 112.4 lb, After Halaven was administered, patient had the following side effects: respiratory failure.

Interstitial Lung Disease (7893154-6)
on Oct 27, 2011 Female patient from JAPAN , weighting 85.98 lb, was diagnosed with
  • recurrent cancer
and was treated with Halaven. Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Halaven dosage: N/A.
Patient also using the following medications:
  • Gemzar
  • Dextromethorphan Hydrobromide
Patient was hospitalized.

Extravasation (7892711-0)
on Oct 25, 2011 Female patient from UNITED STATES , 63 years of age, weighting 233.7 lb, was treated with Halaven. Patient had the following side effects: extravasation. Halaven dosage: N/A.

Febrile Neutropenia (7892587-1)
Patient was taking Halaven. After Halaven was administered, patient had the following side effects: febrile neutropenia on Oct 27, 2011 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with
  • breast cancer recurrent
and. Halaven dosage: N/A.
Patient also using the following medications:
  • Herceptin
  • Tykerb
Patient was hospitalized.

Interstitial Lung Disease, Leukopenia, Thrombocytopenia (7892554-8)
Adverse event was reported on Oct 24, 2011 by a Female patient taking Halaven (Dosage: N/A) was diagnosed with
  • metastases to bone
and. Location: JAPAN , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, leukopenia, thrombocytopenia.
Patient also using the following medications:
  • Lasix
Patient was hospitalized.

Rash, Herpes Zoster Disseminated, Body Temperature Increased, Toxic Epidermal Necrolysis (7888371-5)
on Oct 31, 2011 Female patient from UNITED KINGDOM , 42 years of age, was diagnosed with
  • breast cancer metastatic
and was treated with Halaven. Patient had the following side effects: rash, herpes zoster disseminated, body temperature increased, toxic epidermal necrolysis. Halaven dosage: Unk.
Patient also using the following medications:
  • Phenytoin (Unk)
Patient was hospitalized.

Diarrhoea, Dehydration (7884990-0)
on Oct 24, 2011 Male patient from JAPAN , 56 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. After Halaven was administered, patient had the following side effects: diarrhoea, dehydration. Halaven dosage: N/A. Patient was hospitalized.

Pleural Effusion (7884707-X)
Patient was taking Halaven. Patient experienced the following unwanted or unexpected effects: pleural effusion on Oct 24, 2011 from JAPAN Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with
  • breast cancer recurrent
and. Halaven dosage: N/A. Patient was hospitalized.

Thrombotic Thrombocytopenic Purpura, Interstitial Lung Disease, Fatigue (7831148-7)
Adverse event was reported on Oct 11, 2011 by a Female patient taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
and. Location: JAPAN , 50 years of age, Patient had the following side effects: thrombotic thrombocytopenic purpura, interstitial lung disease, fatigue. Patient was hospitalized.

Renal Failure (7830715-4)
on Oct 10, 2011 Female patient from UNITED STATES , 66 years of age, was diagnosed with
  • breast cancer
and was treated with Halaven. After Halaven was administered, patient had the following side effects: renal failure. Halaven dosage: N/A.

Pleural Effusion, Neoplasm Malignant (7824617-7)
on Oct 07, 2011 Female patient from JAPAN , 46 years of age, weighting 110.2 lb, was diagnosed with
  • metastases to lung
  • metastases to liver
  • breast cancer
  • metastases to bone
and was treated with Halaven. Patient experienced the following unwanted or unexpected effects: pleural effusion, neoplasm malignant. Halaven dosage: N/A. Patient was hospitalized.

  Showing 101-125 of 165 

Did You Have a Halaven Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

Before Taking Halaven

Find Out How to Take Halaven

How Effective is Halaven for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective

Managing Your Medicines

Tips for Taking Medicines Properly


Halaven Information

Alternative HALAVEN Names:ERIBULIN

Substance:ERIBULIN

More About Halaven

Side Effects reported to FDA: 165. View FDA Adverse Reports

Halaven safety alerts: No

Reported deaths: 38

Reported hospitalizations: 112

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

Have Your experienced Halaven Side Effects? You are not alone. Many patients report unusual symptoms after using Halaven. PatientsVille.com raises awareness about Drug Side Effects.

Go to the top of the page

Would You Like to Record Your Side Effects for later use? It is Free and Easy. >> Start Today

Spread the word: Share, Email, Print



How Effective was Halaven for You? Share Your Positive and Negative Experiences.

blog comments powered by Disqus
further research and contacting my doctor

When did you start feeling unusual symptoms? what was the first symptom? Did your symptoms get worse over time? Did you have similar symptoms before using Halaven? What did Your doctor say? Share Your Story

Halaven Adverse Reactions

Leukopenia ( 29 Reports)

Neutropenia ( 26 Reports)

Febrile Neutropenia ( 25 Reports)

Interstitial Lung Disease ( 24 Reports)

Pneumonia ( 17 Reports)

Pyrexia ( 14 Reports)

Stomatitis ( 11 Reports)

Pleural Effusion ( 10 Reports)

Thrombocytopenia ( 9 Reports)

Nausea ( 8 Reports)

Lymphopenia ( 6 Reports)

Neoplasm Malignant ( 6 Reports)

Disseminated Intravascular Coagulation ( 5 Reports)

Hepatic Function Abnormal ( 5 Reports)

Pneumocystis Jiroveci Pneumonia ( 5 Reports)

Convulsion ( 4 Reports)

Dysgeusia ( 4 Reports)

Fatigue ( 4 Reports)

Headache ( 4 Reports)

Hepatic Cirrhosis ( 4 Reports)

Malaise ( 4 Reports)

Sepsis ( 4 Reports)

Thrombotic Thrombocytopenic Purpura ( 4 Reports)

Anaemia ( 3 Reports)

C-reactive Protein Increased ( 3 Reports)

Chest Pain ( 3 Reports)

Hyperbilirubinaemia ( 3 Reports)

Neuropathy Peripheral ( 3 Reports)

Pulmonary Embolism ( 3 Reports)

Rash ( 3 Reports)

side effects
Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!